Also published in Business Insider:
GMI Ratings Governance Issue | Northrop Grumman Corp.
x hide permanently

'Losing direction': Allergan Investors are Unhappy After a Wild 4 Hour Takeover Drama

Business Insider
  • Allergan's stock closed down 4% on Thursday, after the pharma giant said it was "in the early stages of considering a possible offer" for UK-listed Shire, only to say four hours later that it wouldn't make an offer.
  • The drama extends what's been a tough year for the Botox-maker, with the stock vastly underperforming the broader biotech index...
Mentions: Investors CEO Takeover